Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

NCT03503318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

544

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: TV-46000
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.